234 related articles for article (PubMed ID: 36727463)
1. A high triglyceride-glucose index associated with adverse cardiovascular events in patients with type 2 diabetes mellitus and chronic total occlusion after percutaneous coronary intervention.
Lin XL; Li QY; Zhao DH; Liu JH; Fan Q
J Investig Med; 2023 Jun; 71(5):471-481. PubMed ID: 36727463
[TBL] [Abstract][Full Text] [Related]
2. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
4. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion.
Li Y; He S; Wu Z; Li W; Jian W; Cheng Z; Wang C; Shi Y; Liu J
Cardiovasc Diabetol; 2022 Aug; 21(1):149. PubMed ID: 35941586
[TBL] [Abstract][Full Text] [Related]
6. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
7. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
[TBL] [Abstract][Full Text] [Related]
12. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study.
Song Y; Cui K; Yang M; Song C; Yin D; Dong Q; Gao Y; Dou K
Cardiovasc Diabetol; 2023 Jul; 22(1):180. PubMed ID: 37454147
[TBL] [Abstract][Full Text] [Related]
13. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
[TBL] [Abstract][Full Text] [Related]
15. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
Cardiovasc Diabetol; 2021 Feb; 20(1):43. PubMed ID: 33573649
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
17. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.
Tai S; Fu L; Zhang N; Yang R; Zhou Y; Xing Z; Wang Y; Zhou S
Cardiovasc Diabetol; 2022 Aug; 21(1):161. PubMed ID: 35999546
[TBL] [Abstract][Full Text] [Related]
18. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
19. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
